Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

Cardioprotection in AML

NCT04977180

Conditions: AML, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Recruiting

Methods of T Cell Depletion Trial (MoTD)

NCT04888741

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations: University Hospital of Wales Cardiff, Wales, United Kingdom

Queen Elizabeth Hospital Birmingham, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

Addenbrookes Hospital Cambridge, United Kingdom

View all 17 locations

View Trial Details

Recruiting

Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation

NCT07566585

Conditions: AML - Acute Myeloid Leukemia, AML With Mutated NPM1, AML, Adult Recurrent, +11 more
Locations: Washington University at St Louis St Louis, Missouri, United States

View Trial Details

Recruiting

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

NCT07374029

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Recruiting

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

NCT06158828

Conditions: AML, AML, Childhood, Acute Myeloid Leukemia, +8 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT06177067

Conditions: Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Rady Children's Hospital San Diego, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Children's Healthcare of Atlanta Atlanta, Georgia, United States

Children's Mercy Hospital of Kansas City Kansas City, Missouri, United States

View Trial Details

Recruiting

Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

NCT07563179

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +10 more
Locations: Shenzhen University general hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy

NCT07551037

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Recruiting

Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).

NCT07561892

Conditions: Acute Myeloid Leukemia, Chemotherapy Effect, Hematologic Diseases, +7 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Recruiting

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

NCT06696846

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions